FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

32570271000036106: Australian English language reference set (foundation metadata concept)

Status: current, Primitive. Date: 25-Dec 2013. Module: Australian common model component extension

Descriptions:

Id Description Lang Type Status Case? Module
108642491000036119 Australian English (foundation metadata concept) en Fully specified name Inactive Initial character case insensitive SNOMED Clinical Terms Australian extension
108642501000036114 Australian English en Synonym Active Case sensitive Australian common model component extension
108644301000036110 Australian English language reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian common model component extension
108644311000036112 Australian English language reference set en Synonym Active Case sensitive Australian common model component extension
2171000036114 Australian dialect reference set en Synonym Active Case sensitive Australian common model component extension
3306431000168118 ADRS - Australian dialect reference set en Synonym Active Case sensitive Australian common model component extension

943353 members. Search Members:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Australian dialect reference set Is a English true Inferred relationship Some
Members acceptabilityId
2 fingers Preferred
2 hour post-prandial blood glucose level Preferred
2 hour post-prandial blood glucose level Preferred
2 hour urine specimen Preferred
2 hourly Acceptable
2 hours Preferred
2 hours post food blood sugar Acceptable
2 hours post food blood sugar Acceptable
2 hours post-dose Preferred
2 hours post-food blood sugar Acceptable
2 hours post-food blood sugar level Acceptable
2 inch Preferred
2 level of presenting part in relation to ischial spines Preferred
2 male + 1 female babies Acceptable
2 male babies Acceptable
2 o'clock position Preferred
2 o'clock position on mammogram Preferred
2 part fracture Preferred
2 point kneeling Acceptable
2 serotype Preferred
2 serotypes Acceptable
2 times a day Monday, Wednesday and Friday Acceptable
2 to 4 seizures a month Preferred
2 to 4 times a day Acceptable
2 toed sloth Acceptable
2'(3')-polynucleotidase Acceptable
2',3'-cyclic-nucleotide 2'-phosphodiesterase Preferred
2',3'-cyclic-nucleotide 3'-phosphodiesterase Preferred
2'-5'-oligoadenylate synthetase 1-related infantile-onset pulmonary alveolar proteinosis, hypogammaglobulinaemia Acceptable
2'-carboxybenzalpyruvate aldolase Acceptable
2'-deoxyadenosine Acceptable
2'-deoxyguanosine Acceptable
2'-deoxyinosine Acceptable
2'-hydroxydaidzein reductase Preferred
2'-hydroxyisoflavone reductase Preferred
2+ pitting oedema Preferred
2, 3 Diphosphoglycerate Preferred
2,2,2-trichloroethanol Acceptable
2,2,2-trifluoroethanol Preferred
2,2,3,3,4,4,4-heptafluorobutan-1-ol Preferred
2,2,4-trimethyl-1,2-dihydroquinoline Preferred
2,2,4-trimethyl-1,2-dihydroquinoline only product Preferred
2,2,4-trimethyl-1,2-dihydroquinoline-containing product Preferred
2,2,4-trimethylpentane Preferred
2,2-Dichloro-1,1-difluoroethylmethyl ether Preferred
2,2-di(4-methacryloxyphenyl)propane Preferred
2,2-dialkylglycine decarboxylase (pyruvate) Preferred
2,2-dichloro-1,1-difluoroethyl methyl ether Acceptable
2,2-dichloropropanoic acid Acceptable
2,2-dichlorovinyl dimethyl phosphate Acceptable
2,2-dimethylpropane Preferred
2,3 - dihydroxypropanoic acid Acceptable
2,3 DPG - 2,3-diphosphoglycerate Acceptable
2,3 epoxy-1-propanol Acceptable
2,3,4,5-tetrahydropyridine-2-carboxylate N-succinyltransferase Preferred
2,3,5-Trichlorophenoxyacetic acid Preferred
2,3-Diaminopropionate oxalyltransferase Preferred
2,3-bis(sulfanyl)propane-1-sulfonate Preferred
2,3-bis(sulfanyl)propane-1-sulfonate Preferred
2,3-bis(sulfanyl)propane-1-sulfonate sodium Preferred
2,3-bis(sulfanyl)propane-1-sulfonate sodium 250 mg/5 mL injection, 5 x 5 mL ampoules Preferred
2,3-bis(sulfanyl)propane-1-sulfonate sodium 250 mg/5 mL injection, ampoule Preferred
2,3-diaminopropionate N-oxalyltransferase Preferred
2,3-dihydro-2,3-dihydroxybenzoate dehydrogenase Preferred
2,3-dihydro-2,3-dihydroxybenzoate synthase Acceptable
2,3-dihydroxybenzoate 2,3-dioxygenase Preferred
2,3-dihydroxybenzoate 3,4-dioxygenase Preferred
2,3-dihydroxybenzoate serine ligase Preferred
2,3-dihydroxybenzoate-AMP ligase Acceptable
2,3-dihydroxybiphenyl dioxygenase Acceptable
2,3-dihydroxyindole 2,3-dioxygenase Preferred
2,3-dimethylmalate lyase Preferred
2,3-diphosphoglycerate Preferred
2,3-diphosphoglycerate measurement Preferred
2,3-diphosphoglycerate measurement, erythrocytes Preferred
2,3-epoxysqualene cycloartenol-cyclase Acceptable
2,3-epoxysqualene lanosterol-cyclase Acceptable
2,3-pentanedione Preferred
2,4 toluenediamine Preferred
2,4 toluenediamine measurement Preferred
2,4'-dihydroxyacetophenone dioxygenase Preferred
2,4,5-T Acceptable
2,4,5-trichloroacetophenol Preferred
2,4,5-trichloroacetophenol Acceptable
2,4,5-trichlorophenoxyacetic acid Preferred
2,4,5-trihydroxybutyrophenone Preferred
2,4,5-trimethoxyamphetamine Preferred
2,4,6-trihydroxy-1,3,5-triazine Acceptable
2,4,6-trinitrophenol Acceptable
2,4-D Acceptable
2,4-D - 2,4-dichlorophenoxyacetic acid Acceptable
2,4-D causing toxic effect Acceptable
2,4-D poisoning Acceptable
2,4-DB Acceptable
2,4-DB - 4-(2,4-dichlorophenoxy)butyric acid Acceptable
2,4-DNP - dinitrophenol Acceptable
2,4-Dichlorophenoxyacetate measurement Preferred
2,4-Dichlorophenoxyacetic acid poisoning Preferred
2,4-Dinitrophenylhydrazine measurement Preferred
2,4-diaminopentanoate dehydrogenase Preferred
2,4-diaminophenol Preferred

Start Previous Page 45 of 9434 Next End

Reference Sets

Reference set descriptor

Back to Start